Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Aveanna Healthcare (NASDAQ:AVAH) Raises 2026 Guidance as Adjusted EBITDA Climbs 25%

Adjusted EBITDA was USD 100.1 million, a 25% increase over the prior-year period. Management attributed the increase mainly to the improved rate andVolumeenvironment and continued operational efficiencies. Consolidated gross margin was USD 226.8 million, or 32.6% of revenue.

Nitish Kishor | 13 November 2026

Azora Therapeutics (NASDAQ:AZR) Reports Third-Quarter Net Loss of USD 64.6 Million and Cash of USD 22.0 Million

Research and development expenses were USD 1.8 million, against USD 0.5 million in the third quarter of 2025. General and administrative expenses increased approximately USD 4.5 million, or 363%, to USD 5.8 million from USD 1.2 million. Total operating expenses were USD 7.5 million, …

Nitish Kishor | 13 November 2026

Azitra (NYSE American:AZTR) Reports Third-Quarter Operating Expenses of USD 2.9 Million and Cash of USD 3.8 Million

General and administrative expenses for the quarter were USD 1.6 million, against USD 1.6 million a year earlier, a 2% change as shown in the filing.Research and Developmentexpenses were USD 1.3 million, against USD 1.2 million, a 9% change. Loss from operations equaled total …

Nitish Kishor | 13 November 2026

BioCardia (NASDAQ:BCDA) Reports Third-Quarter Net Loss of USD 1.8 Million as Japan Filing and FDA Presubmission Advance

Chief Financial Officer David McClung said net cash used in operations during the third quarter was approximately USD 1.7 million, in line with the USD 1.7 million used in the third quarter of 2025. Year-to-date net cash used in operations was USD 5.1 million, …

Nitish Kishor | 13 November 2026

Birchtech (NYSE American:BCHT) Reports Third-Quarter Product Revenue of USD 5.5 Million With Cash of USD 10.8 Million and No Debt

Chief Executive Officer Richard MacPherson said the quarter included the filing of an appellee brief supporting the company's approximately USD 78 million final judgment, the start of share repurchases, the addition ofBusinessdevelopmentLeadershipfor rural and small water systems and continued work on its first Carbon …

Nitish Kishor | 13 November 2026

HeartBeam (NASDAQ:BEAT) Reports Third-Quarter Net Loss of USD 3.0 Million and FDA Breakthrough Designation for Heart Attack Assessment

Research and development expenses were USD 2.1 million, against USD 3.3 million a year earlier, a decrease of approximately USD 1.2 million, or 35%. Selling, general and administrative expenses were USD 1.3 million, against USD 2.0 million. Total operating expenses were USD 3.5 million, …

Nitish Kishor | 13 November 2026

BK Technologies (NYSE American:BKTI) Reports Third-Quarter Sales of USD 25.3 Million and Updates Full-Year Outlook After HQ Roof Collapse

On the call, management said third-quarter sales totaled USD 25.3 million, an increase of 3.6% from USD 24.4 million in the third quarter of 2025.

Nitish Kishor | 13 November 2026

Beeline Holdings (NASDAQ:BLNE) Reports Third-Quarter Net Revenues of USD 3.0 Million as Loan Origination Fees Rise

Total net revenues were USD 3.0 million for the three months ended September 30, 2026, against USD 2.3 million a year earlier. For the nine months, total net revenues were USD 8.3 million, against USD 5.3 million.

Nitish Kishor | 13 November 2026

BlossomHill Therapeutics (NASDAQ:BLSM) Reports Third-Quarter Net Loss of USD 24.0 Million and Cash of USD 224.9 Million

The filing shows a net loss of USD 24,013 thousand for the third quarter, against USD 15,976 thousand a year earlier.

Nitish Kishor | 13 November 2026

Brookfield Corporation (NYSE:BN) Reports 14% Per-Share Growth in Distributable Earnings Before Realizations

Management said it realized USD 222 million of netCarried Interestinto income during the quarter. That brought total distributable earnings to USD 1.7 billion, or USD 0.73 per share, an increase of 16% per share over the prior-year quarter.

Nitish Kishor | 13 November 2026
Support

Hi! How can we help you today?

Loading…